Cargando…
Prospective validation of a model‐informed precision dosing tool for vancomycin in intensive care patients
AIMS: Vancomycin is an important antibiotic for critically ill patients with Gram‐positive bacterial infections. Critically ill patients typically have severely altered pathophysiology, which leads to inefficacy or toxicity. Model‐informed precision dosing may aid in optimizing the dose, but prospec...
Autores principales: | ter Heine, Rob, Keizer, Ron J., van Steeg, Krista, Smolders, Elise J., van Luin, Matthijs, Derijks, Hieronymus J., de Jager, Cornelis P.C., Frenzel, Tim, Brüggemann, Roger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688533/ https://www.ncbi.nlm.nih.gov/pubmed/32415710 http://dx.doi.org/10.1111/bcp.14360 |
Ejemplares similares
-
Model‐Informed Precision Dosing at the Bedside: Scientific Challenges and Opportunities
por: Keizer, Ron J., et al.
Publicado: (2018) -
A limited sampling schedule to estimate individual pharmacokinetics of pemetrexed in patients with varying renal functions
por: de Rouw, Nikki, et al.
Publicado: (2019) -
Model-Informed Precision Dosing of Everolimus: External Validation in Adult Renal Transplant Recipients
por: Zwart, Tom C., et al.
Publicado: (2020) -
The Pharmacoeconomic Benefits of Pemetrexed Dose Individualization in Patients With Lung Cancer
por: de Rouw, Nikki, et al.
Publicado: (2022) -
Rethinking the Application of Pemetrexed for Patients with Renal Impairment: A Pharmacokinetic Analysis
por: de Rouw, Nikki, et al.
Publicado: (2021)